Our Approach:  We use computational methods and our technologies to accelerate the identification of lead compounds for drug discovery and molecular development campaigns. By doing so, we can significantly reduce the number of compounds that need to be tested in the in vitro discovery stage.
 

Our approach is generic: we can use similar methods to identify active compounds targeting various drug targets that play a role in a wide variety of diseases. 

 

Green means we will find hit molecules faster, at the expense of fewer in vitro testing, requiring less chemical waste, less consumables and less energy in a shorter period of time, thereby leaving a relatively minor footprint on the environment.